BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23078846)

  • 1. A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry.
    Tyan YC; Su SB; Ting SS; Wang HY; Liao PC
    Clin Chim Acta; 2013 May; 420():34-44. PubMed ID: 23078846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling for peritoneal dialysate: differential protein expression in diabetes mellitus.
    Yang MH; Wang HY; Lu CY; Tsai WC; Lin PC; Su SB; Tyan YC
    Biomed Res Int; 2013; 2013():642964. PubMed ID: 23781506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration.
    Cuccurullo M; Evangelista C; Vilasi A; Simeoni M; Avella F; Riccio E; Memoli B; Malorni A; Capasso G
    Nephrol Dial Transplant; 2011 Jun; 26(6):1990-9. PubMed ID: 21079196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis.
    Lin WT; Tsai CC; Chen CY; Lee WJ; Su CC; Wu YJ
    Ren Fail; 2008; 30(8):772-7. PubMed ID: 18791950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate.
    Wang HY; Tian YF; Chien CC; Kan WC; Liao PC; Wu HY; Su SB; Lin CY
    Nephrol Dial Transplant; 2010 Jun; 25(6):1955-63. PubMed ID: 20054029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis.
    Raaijmakers R; Pluk W; Schröder CH; Gloerich J; Cornelissen EA; Wessels HJ; Willems JL; Monnens LA; van den Heuvel LP
    Nephrol Dial Transplant; 2008 Jul; 23(7):2402-5. PubMed ID: 18424818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes.
    Sritippayawan S; Chiangjong W; Semangoen T; Aiyasanon N; Jaetanawanitch P; Sinchaikul S; Chen ST; Vasuvattakul S; Thongboonkerd V
    J Proteome Res; 2007 Nov; 6(11):4356-62. PubMed ID: 17924681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic analysis of peritoneal dialysate from chronic glomerulonephritis patients.
    Wu HY; Liao AC; Huang CC; Liao PC; Chien CC; Kan WC; Wang HY
    Biomed Res Int; 2013; 2013():863860. PubMed ID: 23762862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach.
    Zhou H; Chen B; Li RX; Sheng QH; Li SJ; Zhang L; Li L; Xia QC; Wang HY; Zeng R
    Rapid Commun Mass Spectrom; 2005; 19(23):3569-78. PubMed ID: 16276486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
    J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
    Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
    Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers.
    Liu S; Sun MZ; Tang JW; Wang Z; Sun C; Greenaway FT
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3172-8. PubMed ID: 18798201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of complement C3 protein in chemically induced hepatotumorogenesis in Wistar rats: a correlative proteomics and histopathological study.
    Malik S; Bhatnagar S; Chaudhary N; Katare DP; Jain SK
    Exp Toxicol Pathol; 2013 Sep; 65(6):767-73. PubMed ID: 23245919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.